GPRC5B and major depressive disorder: Furthermore, transcriptional analysis in post-mortem brain from patients suggested an involvement of GPRC5B in signaling pathways leading to bipolar disorders (BPD) and major depressive disorders (MDD) (Aston et al., 2005; Tomita et al., 2013).